Gerresheimer AG (GXI.DE)
EUR 60.55
(1.94%)
EUR 60.55
(1.94%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 116.12 Million EUR | 20.81% |
| 2022 | 96.12 Million EUR | 14.72% |
| 2021 | 83.78 Million EUR | -5.39% |
| 2020 | 88.55 Million EUR | 9.63% |
| 2019 | 80.78 Million EUR | -37.36% |
| 2018 | 128.96 Million EUR | 27.83% |
| 2017 | 100.88 Million EUR | -17.06% |
| 2016 | 121.63 Million EUR | 16.72% |
| 2015 | 104.21 Million EUR | 57.1% |
| 2014 | 66.33 Million EUR | 6.73% |
| 2013 | 62.15 Million EUR | 3.26% |
| 2012 | 60.19 Million EUR | 10.59% |
| 2011 | 54.42 Million EUR | 16.43% |
| 2010 | 46.74 Million EUR | 571.46% |
| 2009 | 6.96 Million EUR | 54.37% |
| 2008 | 4.51 Million EUR | 467.26% |
| 2007 | -1.22 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 13 Million EUR | -68.74% |
| 2024 Q2 | 32.46 Million EUR | 149.55% |
| 2024 Q3 | 27.2 Million EUR | -16.18% |
| 2023 Q3 | 28.02 Million EUR | -18.61% |
| 2023 Q4 | 41.61 Million EUR | 48.49% |
| 2023 FY | 116.12 Million EUR | 20.81% |
| 2023 Q1 | 12.04 Million EUR | -63.36% |
| 2023 Q2 | 34.43 Million EUR | 185.78% |
| 2022 Q3 | 27.34 Million EUR | 8.67% |
| 2022 Q4 | 32.88 Million EUR | 20.28% |
| 2022 FY | 96.12 Million EUR | 14.72% |
| 2022 Q2 | 25.15 Million EUR | 134.41% |
| 2022 Q1 | 10.73 Million EUR | -60.73% |
| 2021 Q2 | 28.13 Million EUR | 205.76% |
| 2021 Q4 | 27.32 Million EUR | 42.87% |
| 2021 FY | 83.78 Million EUR | -5.39% |
| 2021 Q1 | 9.2 Million EUR | -69.37% |
| 2021 Q3 | 19.12 Million EUR | -32.0% |
| 2020 Q1 | 4.13 Million EUR | 104.98% |
| 2020 FY | 88.55 Million EUR | 9.63% |
| 2020 Q4 | 30.03 Million EUR | 18.27% |
| 2020 Q3 | 25.39 Million EUR | -12.38% |
| 2020 Q2 | 28.98 Million EUR | 600.34% |
| 2019 Q4 | -83.18 Million EUR | -550.43% |
| 2019 Q3 | 18.46 Million EUR | -60.34% |
| 2019 Q2 | 46.56 Million EUR | -52.93% |
| 2019 Q1 | 98.93 Million EUR | 129.46% |
| 2019 FY | 80.78 Million EUR | -37.36% |
| 2018 Q1 | 48.65 Million EUR | 28.61% |
| 2018 FY | 128.96 Million EUR | 27.83% |
| 2018 Q3 | 18.42 Million EUR | -1.86% |
| 2018 Q2 | 18.77 Million EUR | -61.42% |
| 2018 Q4 | 43.11 Million EUR | 134.05% |
| 2017 Q1 | 12.92 Million EUR | -71.34% |
| 2017 Q3 | 25.6 Million EUR | 4.34% |
| 2017 Q4 | 37.83 Million EUR | 47.79% |
| 2017 Q2 | 24.53 Million EUR | 89.89% |
| 2017 FY | 100.88 Million EUR | -17.06% |
| 2016 Q3 | 30.93 Million EUR | 5.32% |
| 2016 Q2 | 29.37 Million EUR | 80.83% |
| 2016 Q4 | 45.07 Million EUR | 45.7% |
| 2016 FY | 121.63 Million EUR | 16.72% |
| 2016 Q1 | 16.24 Million EUR | -70.31% |
| 2015 Q4 | 54.71 Million EUR | 200.55% |
| 2015 Q1 | 11.01 Million EUR | -44.63% |
| 2015 Q3 | 18.2 Million EUR | -10.2% |
| 2015 FY | 104.21 Million EUR | 57.1% |
| 2015 Q2 | 20.27 Million EUR | 83.98% |
| 2014 Q1 | 8.95 Million EUR | -63.94% |
| 2014 FY | 66.33 Million EUR | 6.73% |
| 2014 Q4 | 19.9 Million EUR | 9.35% |
| 2014 Q3 | 18.19 Million EUR | -5.63% |
| 2014 Q2 | 19.28 Million EUR | 115.33% |
| 2013 FY | 62.15 Million EUR | 3.26% |
| 2013 Q1 | 8.59 Million EUR | -67.1% |
| 2013 Q2 | 10.73 Million EUR | 24.83% |
| 2013 Q4 | 24.83 Million EUR | 37.99% |
| 2013 Q3 | 17.99 Million EUR | 67.72% |
| 2012 Q4 | 26.12 Million EUR | 93.36% |
| 2012 Q1 | 5.54 Million EUR | -61.24% |
| 2012 FY | 60.19 Million EUR | 10.59% |
| 2012 Q2 | 16.35 Million EUR | 194.76% |
| 2012 Q3 | 13.51 Million EUR | -17.39% |
| 2011 Q2 | 12 Million EUR | 93.57% |
| 2011 Q1 | 6.2 Million EUR | -62.47% |
| 2011 Q3 | 17.99 Million EUR | 49.8% |
| 2011 Q4 | 14.31 Million EUR | -20.43% |
| 2011 FY | 54.42 Million EUR | 16.43% |
| 2010 Q3 | 12.98 Million EUR | 9.66% |
| 2010 Q1 | 1.87 Million EUR | -82.05% |
| 2010 Q4 | 16.53 Million EUR | 27.34% |
| 2010 Q2 | 11.83 Million EUR | 531.7% |
| 2010 FY | 46.74 Million EUR | 571.46% |
| 2009 Q2 | 929 Thousand EUR | 186.99% |
| 2009 FY | 6.96 Million EUR | 54.37% |
| 2009 Q1 | -1.06 Million EUR | 0.0% |
| 2009 Q3 | -4.04 Million EUR | -535.63% |
| 2009 Q4 | 10.44 Million EUR | 358.04% |
| 2008 FY | 4.51 Million EUR | 467.26% |
| 2007 FY | -1.22 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 151.84 Million EUR | 23.522% |
| Carl Zeiss Meditec AG | 290.39 Million EUR | 60.011% |
| Fielmann Aktiengesellschaft | 127.64 Million EUR | 9.024% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 43.408% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 43.408% |